Electroacupuncture and Moxibustion Improved Anxiety Behavior in DSS-Induced Colitis Mice

Overview

Journal Gastroenterol Res Pract

Publisher Wiley

Specialty Gastroenterology

Date 2019 Mar 19

PMID 30881446

Citations 15

Authors

Daneng Wei

Na Zhao

Lushuang Xie

Biao Huang

Zhiqi Zhuang

Yong Tang

Shuguang Yu

Qiaofeng Wu

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Psychological disorders are prevalent in patients with inflammatory bowel disease, but the underlying mechanisms remain unknown. The aim of this study was to study whether electroacupuncture (EA) and moxibustion (MB) can improve anxiety behavior in DSS-induced colitis mice and to investigate whether this effect is related to hypothalamic-pituitary-adrenocortical (HPA) axis.

Methods: The colitis model was established by drinking 2.5% dextran sodium sulfate (DSS). DSS-induced colitis mice were treated by EA or MB. Disease activity index (DAI) was scored; intestinal morphological and pathological structure was observed; anxiety behavior was tested by the elevated plus maze and open field. The concentration of corticotropin-releasing hormone (CRH) and cortisol (CORT) in serum was measured by enzyme-linked immunosorbent assay (ELISA). The protein expression of CRH in the colon and hypothalamus was detected by Western blot (WB).

Results: Both EA and MB treatments can improvethe morphology of their distal colonic mucosal epithelia, as well as the disease activity index. Meanwhile, anxiety behavior in colitis mice was improved slightly after EA and MB treatment. In addition, the levels of CRH and CORT in the serum were slightly improved after EA and MB treatment. These effects are further supported by WB results. The expression of CRH in the colon and hypothalamus was increased significantly after treatment, compared with the model group.

Conclusion: EA and MB were able to regulate the concentration of CRH in serum and protein expression in the peripheral and central at different levels and promote the recovery of the HPA axis that may be the basis for EA and MB to improve colonic pathology and alleviate anxiety behavior in DSS-induced colitis.

Citing Articles

Electroacupuncture Mechanisms in Managing Preoperative Anxiety and Postoperative Pain Chronification: A Review.

Erasmus S, Lyu Z, Zhou J, Fang J, Liang Y J Pain Res. 2024; 17:4089-4100.

PMID: 39650212 PMC: 11625428. DOI: 10.2147/JPR.S498373.

Gastrointestinal Issues in Depression, Anxiety, and Neurodegenerative Diseases: A Systematic Review on Pathways and Clinical Targets Implications.

Andriolo I, Longo B, de Melo D, de Souza M, Prediger R, da Silva L CNS Neurol Disord Drug Targets. 2024; 23(11):1371-1391.

PMID: 38500273 DOI: 10.2174/0118715273289138240306050532.

Electroacupuncture Reduces Inflammatory Bowel Disease in Obese Mice by Activating the Nrf2/HO-1 Signaling Pathways and Repairing the Intestinal Barrier.

Yang Y, Pang F, Zhou M, Guo X, Yang Y, Qiu W Diabetes Metab Syndr Obes. 2024; 17:435-452.

PMID: 38299195 PMC: 10829509. DOI: 10.2147/DMSO.S449112.

Electroacupuncture alleviates ulcerative colitis by targeting CXCL1: evidence from the transcriptome and validation.

Zhang R, Dong L, Shen Y, Li H, Huang Q, Yu S Front Immunol. 2023; 14:1187574.

PMID: 37727787 PMC: 10505654. DOI: 10.3389/fimmu.2023.1187574.

Moxibustion for medical personnel with negative emotion and insomnia during COVID-19 pandemic: A randomized, controlled trial.

Li X, Li X, Wang X, Yin X, Li S, Wu J Integr Med Res. 2023; 12(3):100974.

PMID: 37637182 PMC: 10448013. DOI: 10.1016/j.imr.2023.100974.

References

Michaud C, Murray C, Bloom B . Burden of disease--implications for future research. JAMA. 2001; 285(5):535-9. DOI: 10.1001/jama.285.5.535. View

Kurina L, Goldacre M, Yeates D, Gill L . Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health. 2001; 55(10):716-20. PMC: 1731788. DOI: 10.1136/jech.55.10.716. View

Banki C, Karmacsi L, Bissette G, Nemeroff C . CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse. Eur Neuropsychopharmacol. 1992; 2(2):107-13. DOI: 10.1016/0924-977x(92)90019-5. View

Mittermaier C, Dejaco C, Waldhoer T, Oefferlbauer-Ernst A, Miehsler W, Beier M . Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med. 2004; 66(1):79-84. DOI: 10.1097/01.psy.0000106907.24881.f2. View

Anton P, Gay J, Mykoniatis A, Pan A, OBrien M, Brown D . Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation. Proc Natl Acad Sci U S A. 2004; 101(22):8503-8. PMC: 420423. DOI: 10.1073/pnas.0402693101. View

Tabosa A, Yamamura Y, Forno E, Mello L . A comparative study of the effects of electroacupuncture and moxibustion in the gastrointestinal motility of the rat. Dig Dis Sci. 2004; 49(4):602-10. DOI: 10.1023/b:ddas.0000026305.20852.41. View

Jones M, Dilley J, Drossman D, Crowell M . Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil. 2006; 18(2):91-103. DOI: 10.1111/j.1365-2982.2005.00730.x. View

Lowry C, Moore F . Regulation of behavioral responses by corticotropin-releasing factor. Gen Comp Endocrinol. 2006; 146(1):19-27. DOI: 10.1016/j.ygcen.2005.12.006. View

Kokkotou E, Torres D, Moss A, OBrien M, Grigoriadis D, Karalis K . Corticotropin-releasing hormone receptor 2-deficient mice have reduced intestinal inflammatory responses. J Immunol. 2006; 177(5):3355-61. DOI: 10.4049/jimmunol.177.5.3355. View

10.

Graff L, Walker J, Lix L, Clara I, Rawsthorne P, Rogala L . The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Clin Gastroenterol Hepatol. 2006; 4(12):1491-1501. DOI: 10.1016/j.cgh.2006.09.027. View

11.

Fukudo S . Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol. 2007; 42 Suppl 17:48-51. DOI: 10.1007/s00535-006-1942-7. View

12.

Wang Y, OuYang Q . Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients. J Gastroenterol Hepatol. 2007; 22(9):1450-5. DOI: 10.1111/j.1440-1746.2007.04873.x. View

13.

de Kloet C, Vermetten E, Geuze E, Lentjes E, Heijnen C, Stalla G . Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder. Prog Brain Res. 2007; 167:287-91. DOI: 10.1016/S0079-6123(07)67025-3. View

14.

Kovacs Z, Kovacs F . Depressive and anxiety symptoms, dysfunctional attitudes and social aspects in irritable bowel syndrome and inflammatory bowel disease. Int J Psychiatry Med. 2008; 37(3):245-55. DOI: 10.2190/PM.37.3.a. View

15.

Walker E, Mittal V, Tessner K . Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol. 2008; 4:189-216. DOI: 10.1146/annurev.clinpsy.4.022007.141248. View

16.

Miehsler W, Weichselberger M, Offerlbauer-Ernst A, Dejaco C, Reinisch W, Vogelsang H . Which patients with IBD need psychological interventions? A controlled study. Inflamm Bowel Dis. 2008; 14(9):1273-80. DOI: 10.1002/ibd.20462. View

17.

Wang H, Qi H, Wang B, Cui Y, Zhu L, Rong Z . Is acupuncture beneficial in depression: a meta-analysis of 8 randomized controlled trials?. J Affect Disord. 2008; 111(2-3):125-34. DOI: 10.1016/j.jad.2008.04.020. View

18.

Cui C, Wu L, Luo F . Acupuncture for the treatment of drug addiction. Neurochem Res. 2008; 33(10):2013-22. DOI: 10.1007/s11064-008-9784-8. View

19.

Kappelman M, Rifas-Shiman S, Porter C, Ollendorf D, Sandler R, Galanko J . Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology. 2008; 135(6):1907-13. PMC: 2613430. DOI: 10.1053/j.gastro.2008.09.012. View

20.

Belda X, Rotllant D, Fuentes S, Delgado R, Nadal R, Armario A . Exposure to severe stressors causes long-lasting dysregulation of resting and stress-induced activation of the hypothalamic-pituitary-adrenal axis. Ann N Y Acad Sci. 2009; 1148:165-73. DOI: 10.1196/annals.1410.038. View